Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults

  • Technology appraisal guidance
  • TA170
  • Published: 
Download guidance (PDF)

1 Recommendations

1.1

Rivaroxaban, within its marketing authorisation, is recommended as an option for the prevention of venous thromboembolism in adults having elective total hip replacement surgery or elective total knee replacement surgery.